13F HOLDINGS REPORT
Opaleye Management Inc.
Quarter ended Q4 2023 · Filed November 15, 2023 · Accession 0001493152-23-041364
Total Value
$307.4M
Positions
41
Other Managers
0
Confidential Omitted
No
Holdings (41)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | HARROW HEALTH INC | HROW | 3,795,000 | $54.5M | 17.74% |
| 2 | ACELYRIN INC | 00445A100 | 4,146,138 | $42.2M | 13.72% |
| 3 | OCULAR THERAPEUTIX INC | OCUL | 6,468,000 | $20.3M | 6.61% |
| 4 | TG THERAPEUTICS INC | TGTX | 1,890,000 | $15.8M | 5.14% |
| 5 | RHYTHM PHARMACEUTICALS INC | RYTM | 653,000 | $15.0M | 4.87% |
| 6 | CATALYST PHARMACEUTICALS INC | CPRX | 1,205,000 | $14.1M | 4.58% |
| 7 | KEROS THERAPEUTICS INC | KROS | 360,400 | $11.5M | 3.74% |
| 8 | BIOHAVEN LTD | BHVN | 439,000 | $11.4M | 3.71% |
| 9 | CRINETICS PHARMACEUTICALS INC | CRNX | 370,000 | $11.0M | 3.58% |
| 10 | ETON PHARMACEUTICALS INC | ETON | 2,430,270 | $10.1M | 3.30% |
| 11 | IDEAYA BIOSCIENCES INC | IDYA | 311,500 | $8.4M | 2.73% |
| 12 | MORPHOSYS AG | 617760202 | 1,209,380 | $8.1M | 2.64% |
| 13 | TELA BIO INC | TELA | 750,000 | $6.0M | 1.95% |
| 14 | EDGEWISE THERAPEUTICS INC | EWTX | 875,405 | $5.0M | 1.63% |
| 15 | KALVISTA PHARMACEUTICALS INC | KALV | 500,000 | $4.8M | 1.57% |
| 16 | MARINUS PHARMACEUTICALS INC | 56854Q200 | 584,000 | $4.7M | 1.53% |
| 17 | VAXCYTE INC | PCVX | 90,000 | $4.6M | 1.49% |
| 18 | PROTARA THERAPEUTICS INC | TARA | 2,692,594 | $4.5M | 1.46% |
| 19 | UROGEN PHARMA LTD | URGN | 320,000 | $4.5M | 1.46% |
| 20 | GERON CORP | GERN | 1,915,000 | $4.1M | 1.32% |
| 21 | GOSSAMER BIO INC | GOSS | 4,754,200 | $4.0M | 1.29% |
| 22 | 4D MOLECULAR THERAPEUTICS INC | FDMT | 308,500 | $3.9M | 1.28% |
| 23 | XOMA CORP DEL | XOMAP | 274,500 | $3.9M | 1.26% |
| 24 | TREVI THERAPEUTICS INC | TRVI | 1,705,900 | $3.7M | 1.21% |
| 25 | LIQUIDIA CORPORATION | LQDA | 570,700 | $3.6M | 1.18% |
| 26 | LARIMAR THERAPEUTICS INC | LRMR | 848,500 | $3.4M | 1.09% |
| 27 | NYXOAH S A | NYXH | 441,896 | $3.1M | 1.01% |
| 28 | GOSSAMER BIO INC | GOSS | 8,000,000 | $3.1M | 1.01% |
| 29 | IOVANCE BIOTHERAPEUTICS INC | IOVA | 610,000 | $2.8M | 0.90% |
| 30 | BRIDGEBIO PHARMA INC | BDSX | 92,500 | $2.4M | 0.79% |
| 31 | APPLIED THERAPEUTICS | 03828A101 | 893,000 | $2.2M | 0.72% |
| 32 | IGM BIOSCIIENCES INC | 449585108 | 261,000 | $2.2M | 0.71% |
| 33 | CODEXIS INC | CDXS | 1,118,900 | $2.1M | 0.69% |
| 34 | VERASTEM INC | VSTM | 211,400 | $1.7M | 0.56% |
| 35 | PRECIGEN INC | PGEN | 928,500 | $1.3M | 0.43% |
| 36 | TRACON PHARMACEUTICALS INC | 89237H209 | 4,764,508 | $848,082 | 0.28% |
| 37 | XERIS BIOPHARMA HOLDINGS INC | XERS | 390,000 | $725,400 | 0.24% |
| 38 | BIODESIX | BDSX | 363,073 | $599,070 | 0.19% |
| 39 | FORTRESS BIOTECH INC | FBIOP | 2,000,000 | $580,600 | 0.19% |
| 40 | KEZAR LIFE SCIENCES INC | KZR | 425,000 | $505,750 | 0.16% |
| 41 | RELMADA THERAPEUTICS INC | RLMD | 30,000 | $90,000 | 0.03% |